[HTML] plos.org

[HTML][HTML] Dabigatran for the treatment and secondary prevention of venous thromboembolism; a cost-effectiveness analysis for the Netherlands

J Stevanović, LA De Jong, BS Kappelhoff… - PLoS …, 2016 - journals.plos.org
Background Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …
被引用次数：19 相关文章
[HTML] nih.gov

[HTML][HTML] Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanović, LA de Jong, BS Kappelhoff, EP Dvortsin… - PLoS ONE, 2016 - ncbi.nlm.nih.gov
Background Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanović, LA de Jong, BS Kappelhoff… - PloS …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanović, LA de Jong, BS Kappelhoff… - PLOS …, 2016 - econpapers.repec.org
Background: Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanovic, LA de Jong, BS Kappelhoff, EP Dvortsin… - PLoS ONE, 2016 - go.gale.com
Background Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …
[PDF] core.ac.uk

[PDF][PDF] Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanović, LA de Jong, BS Kappelhoff, EP Dvortsin… - PLOS ONE, 2016 - core.ac.uk
Background Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …
[PDF] semanticscholar.org

[PDF][PDF] Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanović, LA de Jong, BS Kappelhoff… - PLoS …, 2016 - pdfs.semanticscholar.org
Background Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanović, LA de Jong, BS Kappelhoff, EP Dvortsin… - PLOS ONE, 2016 - ideas.repec.org
Background: Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands.

J Stevanović, LA de Jong, BS Kappelhoff, EP Dvortsin… - Plos one, 2016 - europepmc.org
Background Dabigatran was proven to have similar effect on the prevention of recurrence of
venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K …

[引用][C] Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

J Stevanović, LA de Jong, BS Kappelhoff… - PLoS …, 2016 - ui.adsabs.harvard.edu
Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A
Cost-Effectiveness Analysis for the Netherlands - NASA/ADS Now on home page ads icon …